5250
D. B. Ramachary, M. Shiva Prasad / Tetrahedron Letters 51 (2010) 5246–5251
2. General experimental procedures for the TCRA reactions:
proline-catalyzed cascade TCRA reactions
In a glass vial equipped with a magnetic stirring bar, to
0.5 mmol of arylacetonitrile 1, 0.5 mmol of the aldehyde/ketone
2 and 0.75 mmol of 2,6-dimethyl-3,5-diacetyl-1,4-dihydropyridine
3c was added 1.0 mL of DMSO, followed by the catalyst amino acid
4a (0.1 mmol). The reaction mixture was stirred at 25 °C for the
time indicated in Tables 1–3. The crude reaction mixture was
worked up with aqueous NH4Cl solution and the aqueous layer
was extracted with dichloromethane (2 ꢀ 20 mL). The combined
organic layers were dried (Na2SO4), filtered, and concentrated. Pure
TCRA products 6 were obtained by column chromatography [silica
gel, mixture of hexane/ethylacetate (90/10)].
Scheme 3. Applications of cascade TCRA reactions.
3. H2SO4-Catalyzed hydrolysis reactions of 6
A solution of substituted 2-aryl-propionitrile 6 (0.5 mmol) and
H2SO4 (1.5 mL, 50%) in 1, 4-dioxane solvent (1.0 mL) was stirred at
100 °C for 24 h. The reaction mixture was cooled and aqueous layer
was made basic with 1 N aqueous NaOH and then un-reacted start-
ing materials were extracted with CH2Cl2 (2 ꢀ 5 mL). Then the aque-
ous layer was acidified with 10% H2SO4 and the compound was
extracted with CH2Cl2 (3 ꢀ 10 mL). The combined in CH2Cl2 extract
was washed with brine and dried (anhydrous Na2SO4). Evaporation
of the solvent afforded the pure 2-arylpropionic acids 7.
Many of the TCRA products 6 and 7 are commercially available
or have been synthesized previously, and their analytical data
match literature values; and new compounds were characterized
on the basis of IR, 1H and 13C NMR, and analytical data (see Supple-
mentary data).
the presence of more water in the reaction (Table S3, see Supple-
mentary data). TCRA products 6aa–ar and analogs are very impor-
tant intermediates for the synthesis of NSAIDs (A–D) and their
drug-analogs.1 Recently, Jones and co-workers reported the asym-
metric synthesis of (R)-aminoglutethimide C (useful as treatment
for the hormone-dependent breast cancer) from key intermediate
6ap, which was prepared in three-steps starting from 1-chloro-4-
nitrobenzene with <40% overall yield.1d Utilizing the presently
developed TCRA method, we produced the drug intermediate 6ap
in 50% yield in a single step as shown in Table 3 and Scheme 3.
As shown in Table 3, TCRA reaction of (4-nitro-phenyl)-acetoni-
trile 1a with 3.0 equiv of acetone 2s and 1.5 equiv of 3c under the
4a-/self-catalysis in DMSO at 25 °C for 24 h furnished the olefin
derivative 5as in 85% yield instead of expected 6as (entry 19).
Same TCRA reaction of 1a, 3c (1.5 equiv) with 1.5 equiv of cyclo-
hexanone 2t also furnished the olefin derivative 5at as major prod-
uct instead of expected 6at (entry 20). Formation of intermediate
olefins 5as–at instead of expected alkylation products 6as–at from
TCRA reactions could be explained based on the steric and elec-
tronic factors.5
Acknowledgments
This work was made possible by a grant from the Department of
Science and Technology (DST), New Delhi [Grant No.: DST/SR/S1/
OC-65/2008]. M.S.P. thanks CSIR (New Delhi) for his research
fellowship.
Based on the demand of pharmaceutical applications, we fur-
ther extended the TCRA products 6 into more useful intermediates
7 as shown in Scheme 3. Hydrolysis products 7 were obtained in
very good yields with high selectivity and purity without column
purification through acid-catalysis on 6 as shown in Scheme 3. This
method will be showing much impact on the synthesis of 2-aryl-
propionic acids 7. Compounds 7 have gained importance in recent
years as intermediates for the synthesis of NSAIDs.1 Hydrolysis of
6aa under 30 mol % of H2SO4-catalysis furnished the 2-(4-nitro-
phenyl)-3-phenyl-propionic acid 7aa in 75% yield as shown in
Scheme 3. Generality of the H2SO4-catalyzed hydrolysis of 6 was
further confirmed by two more examples using 6ap and 6ar to fur-
nish the expected 7ap in 95% yield and 7ar in 97% yield, respec-
tively as shown in Scheme 3. For the pharmaceutical
applications, high-yielding synthesis of diversity-oriented library
of substituted 2-arylpropionic acids 7 could be generated by using
our two-step sequence of proline-/self-catalyzed TCRA reaction fol-
lowed by H2SO4-catalyzed hydrolysis reaction.
In summary, we have developed a direct amino acid-/self-cata-
lyzed cascade TCRA reactions of arylacetonitriles 1 containing elec-
tron withdrawing groups with aldehydes 2 and organic-hydride 3c,
which has direct applications in drug discovery process. Also we
have developed the two-step sequence to synthesize 2-arylpropi-
onic acids 7 with very good yields, which are useful as NSAIDs. Fur-
ther work is in progress to utilize novel cascade TCRA products 6 as
starting materials for the development of asymmetric cascade Mi-
chael-aldol reactions.
A. Supplementary data
General experimental procedures, compound characterization,
X-ray crystal structure and analytical data (IR, 1H NMR and 13C
NMR) for all new compounds. Copies of the 1H NMR and 13C
NMR spectra of all new compounds. Supplementary data associ-
ated with this article can be found, in the online version, at
References and notes
1. (a) Yadav, M. R.; Pawar, V. P.; Marvaniya, S. M.; Halen, P. K.; Giridhar, R.; Mishra,
A. K. Bioorg. Med. Chem. 2008, 16, 9443–9449; (b) Andreu, I.; Morera, I. M.; Bosc´a,
F.; Sanchez, L.; Camps, P.; Miranda, M. A. Org. Biomol. Chem. 2008, 6, 860–867;
(c) Norinder, J.; Bogar, K.; Kanupp, L.; Baeckvall, J.-E. Org. Lett. 2007, 9, 5095–
5098; (d) Bunegar, M. J.; Dyer, U. C.; Evans, G. R.; Hewitt, R. P.; Jones, S. W.;
Henderson, N.; Richards, C. J.; Sivaprasad, S.; Skead, B. M.; Stark, M. A.; Teale, E.
Org. Process Res. Dev. 1999, 3, 442–450.
2. (a) Jeanty, M.; Suzenet, F.; Guillaumet, G. J. Org. Chem. 2008, 73, 7390–7393; (b)
Motokura, K.; Fujita, N.; Mori, K.; Mizugaki, T.; Ebitani, K.; Jitsukawa, K.; Kaneda,
K. Chem. Eur. J. 2006, 12, 8228–8239; (c) Black, P. J.; Cami-Kobeci, G.; Edwards,
M. G.; Slatford, P. A.; Whittlesey, M. K.; Williams, J. M. J. Org. Biomol. Chem. 2006,
4, 116–125; (d) Slatford, P. A.; Whittlesey, M. K.; Williams, J. M. J. Tetrahedron
Lett. 2006, 47, 6787–6789; (e) Chen, W.; Liu, B.; Yang, C.; Xie, Y. Tetrahedron Lett.
2006, 47, 7191–7193; (f) Loupy, A.; Pellet, M.; Petit, A.; Vo-Thanh, G. Org. Biomol.
Chem. 2005, 3, 1534–1540; (g) Motokura, K.; Nishimura, D.; Mori, K.; Mizugaki,
T.; Ebitani, K.; Kaneda, K. J. Am. Chem. Soc. 2004, 126, 5662–5663.
3. For recent papers on development of MCC reactions, see: (a) Ramachary, D. B.;
Ramakumar, K.; Narayana, V. V. J. Org. Chem. 2007, 72, 1458–1463; (b)
Ramachary, D. B.; Sakthidevi, R. Org. Biomol. Chem. 2008, 6, 2488–2492; (c)